The technology is ready to start phase 3 testing in GSK’s asthma product Ventolin (salbutamol) next year, and according to the drugmaker has the potential to reduce greenhouse gas emissions from ...

People with asthma, chronic obstructive pulmonary disease (COPD), and other breathing issues take salbutamol, typically using an ... prompted drugmaker GlaxoSmithKline to stop manufacturing the ...

People with asthma, chronic obstructive pulmonary disease (COPD), and other breathing issues take salbutamol ... prompted drugmaker GlaxoSmithKline to stop manufacturing the medicine and pull ...

Several single-dose studies comparing acute bronchodilation induced by ipratropium bromide with salbutamol have shown ... Chiesi, GlaxoSmithKline, MSD, Menarini, Novartis and Nycomed.

The Food and Drug Administration on Tuesday approved GSK’s drug for a common type of urinary tract infection (UTI) in women and adolescent girls, one of five new approvals the British drugmaker ...

In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against other stocks that Jim Cramer discussed. On Tuesday, Jim Cramer, host of Mad Money, defended the growing wave ...

GSK Plc is pushing the UK government to give pharmaceutical companies more access to its public health data troves, to accelerate drug development and halt the nation’s slide down global life ...

With Sunday’s Academy Awards ceremony in the rearview mirror, GSK is looking ahead to a potential blockbuster premiere of its own. The British Big Pharma has filed depemokimab for FDA approval ...

GSK (GSK) announced the US Food and Drug Administration, FDA, has accepted for review the Biologics License Application, BLA, for the use of depemokimab in two indications. The proposed ...

GSK has reached an agreement that it says will resolve 93% of the outstanding lawsuits brought against the company claiming that its gastrointestinal drug Zantac caused cancer. The company has ...